Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GTCreator, a flexible annotation tool for image-based datasets

  • Bernal del Nozal, Jorge|||0000-0001-8493-9514
  • Histace, Aymeric|||0000-0002-3029-4412
  • Masana, Marc|||0000-0003-3254-3096
  • Angermann, Quentin
  • Sánchez Montes, Cristina|||0000-0002-9692-9521
  • Rodríguez De Miguel, Cristina|||0000-0002-5576-0854
  • Hammami, Maroua
  • García-Rodríguez, Ana
  • Córdova, Henry|||0000-0002-6636-6764
  • Romain, Olivier
  • Fernández-Esparrach, Gloria|||0000-0002-3378-3940
  • Dray, Xavier
  • Sánchez, F. Javier|||0000-0002-9364-3122
Purpose:: Methodology evaluation for decision support systems for health is a time-consuming task. To assess performance of polyp detection methods in colonoscopy videos, clinicians have to deal with the annotation of thousands of images. Current existing tools could be improved in terms of flexibility and ease of use. Methods:: We introduce GTCreator, a flexible annotation tool for providing image and text annotations to image-based datasets. It keeps the main basic functionalities of other similar tools while extending other capabilities such as allowing multiple annotators to work simultaneously on the same task or enhanced dataset browsing and easy annotation transfer aiming to speed up annotation processes in large datasets. Results:: The comparison with other similar tools shows that GTCreator allows to obtain fast and precise annotation of image datasets, being the only one which offers full annotation editing and browsing capabilites. Conclusion:: Our proposed annotation tool has been proven to be efficient for large image dataset annotation, as well as showing potential of use in other stages of method evaluation such as experimental setup or results analysis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Computer-aided prediction of polyp histology on white light colonoscopy using surface pattern analysis

  • Sánchez Montes, Cristina|||0000-0002-9692-9521
  • Sánchez, F. Javier|||0000-0002-9364-3122
  • Bernal del Nozal, Jorge|||0000-0001-8493-9514
  • Córdova, Henry|||0000-0002-6636-6764
  • Lopez-Ceron, Maria|||0000-0002-7968-9204
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Rodríguez De Miguel, Cristina|||0000-0002-5576-0854
  • García-Rodríguez, Ana
  • Garcés-Durán, Rodrigo
  • Pellisé, Maria|||0000-0001-9739-4998
  • Llach, Josep
  • Fernández-Esparrach, Gloria|||0000-0002-3378-3940
Background This study aimed to evaluate a new computational histology prediction system based on colorectal polyp textural surface patterns using high definition white light images. Methods Textural elements (textons) were characterized according to their contrast with respect to the surface, shape, and number of bifurcations, assuming that dysplastic polyps are associated with highly contrasted, large tubular patterns with some degree of bifurcation. Computer-aided diagnosis (CAD) was compared with pathological diagnosis and the diagnosis made by endoscopists using Kudo and Narrow-Band Imaging International Colorectal Endoscopic classifications. Results Images of 225 polyps were evaluated (142 dysplastic and 83 nondysplastic). The CAD system correctly classified 205 polyps (91.1 %): 131/142 dysplastic (92.3 %) and 74/83 (89.2 %) nondysplastic. For the subgroup of 100 diminutive polyps (≤ 5 mm), CAD correctly classified 87 polyps (87.0 %): 43/50 (86.0 %) dysplastic and 44/50 (88.0 %) nondysplastic. There were no statistically significant differences in polyp histology prediction between the CAD system and endoscopist assessment. Conclusion A computer vision system based on the characterization of the polyp surface in white light accurately predicted colorectal polyp histology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications

  • Franch-Expósito, Sebastià|||0000-0002-4542-1701
  • Bassaganyas, Laia|||0000-0002-4575-0214
  • Vila-Casadesús, Maria|||0000-0001-6597-7953
  • Hernández-Illán, Eva
  • Esteban-Fabró, Roger
  • Díaz-Gay, Marcos|||0000-0003-0658-0467
  • Lozano, Juan José
  • Castells, Antoni|||0000-0001-8431-2033
  • Llovet, Josep Maria
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Camps Polo, Jordi|||0000-0003-2929-4228
Somatic copy number alterations (CNAs) are a hallmark of cancer, but their role in tumorigenesis and clinical relevance remain largely unclear. Here, we developed CNApp, a web-based tool that allows a comprehensive exploration of CNAs by using purity-corrected segmented data from multiple genomic platforms. CNApp generates genome-wide profiles, computes CNA scores for broad, focal and global CNA burdens, and uses machine learning-based predictions to classify samples. We applied CNApp to the TCGA pan-cancer dataset of 10,635 genomes showing that CNAs classify cancer types according to their tissue-of-origin, and that each cancer type shows specific ranges of broad and focal CNA scores. Moreover, CNApp reproduces recurrent CNAs in hepatocellular carcinoma and predicts colon cancer molecular subtypes and microsatellite instability based on broad CNA scores and discrete genomic imbalances. In summary, CNApp facilitates CNA-driven research by providing a unique framework to identify relevant clinical implications. CNApp is hosted at . In most cases, human cells contain two copies of each of their genes, yet sometimes this can change, an effect called copy number alteration (CNA). Cancer is a genetic disease and thus, studying the DNA from tumor samples is crucial to improving diagnosis and choosing the right treatment. Most tumors contain cells with CNAs; however, the impact of CNAs in cancer progression is poorly understood. CNAs can be studied by examining the genome of tumor cells and finding which regions display an unusual number of copies. It may also be possible to gather information about different cancer types by analyzing the CNAs in a tumor, but this approach requires the analysis of large amounts of data. To aid the analysis of CNAs in cancer cells, Franch-Expósito, Bassaganyas et al. have created an online tool called CNApp, which is able to identify and count CNAs in genomic data and link them to features associated with different cancers. The hope is that a better understanding of the effect of CNAs in cancer could help better diagnose cancers, and improve outcomes for patients. Potentially, this could also predict what type of treatment would work better for a specific tumor. Besides, by using a machine-learning approach, the tool can also make predictions about specific cancer subtypes in order to facilitate clinical decisions. Franch-Expósito, Bassaganyas et al. tested CNApp using previously existing cancer data from 33 different cancer types to show how CNApp can help the interpretation of CNAs in cancer. Moreover, CNApp can also use CNAs to identify different types of bowel (colorectal) cancer in a way that could help doctors to make decisions about treatment. Together these findings show that CNApp provides an adaptable and accessible research tool for the study of cancer genomics, which could provide opportunities to inform medical procedures.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Complete loss of epcam immunoexpression identifies epcam deletion carriers in msh2negative colorectal neoplasia

  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Gorostiaga, Iñigo|||0000-0003-0359-9963
  • Riera, Cristina|||0000-0002-3522-5598
  • Saperas, Esteban
  • Llort, Gemma|||0000-0001-9987-7862
  • Costa, Irmgard|||0000-0001-5760-8293
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Carrato, Cristina|||0000-0002-1953-8287
  • Navarro, Matilde Y.
  • Pineda, Marta|||0000-0002-5403-5845
  • Dueñas Cid, Nuria|||0000-0001-6624-3265
  • Brunet, Joan|||0000-0003-1945-3512
  • Marco-Molina, Vicente
  • Trias, Isabel|||0000-0001-9841-4380
  • Busteros-Moraza, José Ignacio
  • Mateu, Gemma
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Fernández-Figueras, Maria Teresa|||0000-0002-2366-7110
  • Esteller, M.|||0000-0003-4490-6093
  • Musulén, Eva|||0000-0002-9667-6464
The use of epithelial cell adhesion molecule (EPCAM) immunohistochemistry (IHC) is not included in the colorectal cancer (CRC) screening algorithm to detect Lynch syndrome (LS) patients. The aim of the present study was to demonstrate that EPCAM IHC is a useful tool to guide the LS germ-line analysis when a loss of MSH2 expression was present. We retrospectively studied MSH2 and EPCAM IHC in a large series of 190 lesions composed of malignant neoplasms (102), precursor lesions of gastrointestinal (71) and extra-gastrointestinal origin (9), and benign neoplasms (8) from different organs of 71 patients suspicious of being LS due to MSH2 alterations. LS was confirmed in 68 patients, 53 with MSH2 mutations and 15 with EPCAM 3'-end deletions. Tissue microarrays were constructed with human normal tissues and their malignant counterparts to assist in the evaluation of EPCAM staining. Among 154 MSH2-negative lesions, 17 were EPCAM-negative, including 10 CRC and 7 colorectal polyps, and 5 of them showed only isolated negative glands. All lesions showing a lack of EPCAM expression belonged to patients with EPCAM 3'-end deletions. EPCAM IHC is a useful screening tool, with 100% specificity to identify LS patients due to EPCAM 3'-end deletions in MSH2-negative CRC and MSH2-negative colorectal polyps.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Álvarez-Barona, Miriam|||0000-0002-3843-7481
  • Quintana, Isabel
  • López-Novo, Jorge Amigo
  • Amigo, Jorge|||0000-0002-1362-2605
  • Cameselle-Teijeiro, José Manuel|||0000-0002-5516-8914
  • Roman, Eva|||0000-0001-9084-8555
  • Gonzalez, Dolors
  • Llor, Xavier|||0000-0002-6259-185X
  • Bujanda, Luis|||0000-0002-4353-9968
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Jover, Rodrigo
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Castells, Antoni|||0000-0001-8431-2033
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Capella, Gabriel|||0000-0002-4669-7320
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Valle, Laura|||0000-0003-0371-0844
  • Ruiz-Ponte, Clara|||0000-0002-2200-0162
Colorectal cancer (CRC) is a complex disease that can be caused by a spectrum of genetic variants ranging from low to high penetrance changes, that interact with the environment to determine which individuals will develop the disease. In this study, we sequenced 20 early-onset CRC patients to discover novel genetic variants that could be linked to the prompt disease development. Eight genes, CHAD, CHD1L, ERCC6, IGTB7, PTPN13, SPATA20, TDG and TGS1, were selected and re-sequenced in a further 304 early onset CRC patients to search for rare, high-impact variants. Although we found a recurring truncating variant in the TDG gene shared by two independent patients, the results obtained did not help consolidate any of the candidates as promising CRC predisposing genes. However, we found that potential risk alleles in our extended list of candidate variants have a tendency to appear at higher numbers in younger cases. This supports the idea that CRC onset may be oligogenic in nature and may show molecular heterogeneity. Further, larger and robust studies are thus needed to unravel the genetics behind early-onset CRC development, coupled with novel functional analyses and omic approaches that may offer complementary insight.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In vivo computer-aided diagnosis of colorectal polyps using white light endoscopy

  • García-Rodríguez, Ana
  • Tudela, Yael
  • Córdova, Henry|||0000-0002-6636-6764
  • Carballal, Sabela
  • Ordás, Ingrid|||0000-0001-7632-0340
  • Moreira, Leticia|||0000-0002-4518-8591
  • Vaquero, Eva|||0000-0003-0098-5295
  • Ortiz, Oswaldo
  • Rivero, Liseth
  • Sánchez, F. Javier|||0000-0002-9364-3122
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Pellisé, Maria|||0000-0001-9739-4998
  • Bernal del Nozal, Jorge|||0000-0001-8493-9514
  • Fernández-Esparrach, Gloria|||0000-0002-3378-3940
Background and study aims Artificial intelligence is currently able to accurately predict the histology of colorectal polyps. However, systems developed to date use complex optical technologies and have not been tested in vivo. The objective of this study was to evaluate the efficacy of a new deep learning-based optical diagnosis system, ATENEA, in a real clinical setting using only high-definition white light endoscopy (WLE) and to compare its performance with endoscopists. Methods ATENEA was prospectively tested in real life on consecutive polyps detected in colorectal cancer screening colonoscopies at Hospital Clínic. No images were discarded, and only WLE was used. The in vivo ATENEA's prediction (adenoma vs non-adenoma) was compared with the prediction of four staff endoscopists without specific training in optical diagnosis for the study purposes. Endoscopists were blind to the ATENEA output. Histology was the gold standard. Results Ninety polyps (median size: 5 mm, range: 2-25) from 31 patients were included of which 69 (76.7 %) were adenomas. ATENEA correctly predicted the histology in 63 of 69 (91.3 %, 95 % CI: 82 %-97 %) adenomas and 12 of 21 (57.1 %, 95 % CI: 34 %-78 %) non-adenomas while endoscopists made correct predictions in 52 of 69 (75.4 %, 95 % CI: 60 %-85 %) and 20 of 21 (95.2 %, 95 % CI: 76 %-100 %), respectively. The global accuracy was 83.3 % (95 % CI: 74%-90 %) and 80 % (95 % CI: 70 %-88 %) for ATENEA and endoscopists, respectively. Conclusion ATENEA can accurately be used for in vivo characterization of colorectal polyps, enabling the endoscopist to make direct decisions. ATENEA showed a global accuracy similar to that of endoscopists despite an unsatisfactory performance for non-adenomatous lesions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cytology Smears, An Enhanced Alternative Method for Colorectal Cancer pN Stage-A Multicentre Study

  • Diaz-Mercedes, Sherley|||0000-0002-8164-8639
  • Archilla, Ivan|||0000-0002-2142-0608
  • Lahoz, Sara|||0000-0002-4491-9911
  • Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Tarragona, Jordi|||0000-0002-1459-4087
  • Landolfi, Stefania|||0000-0002-1059-635X
  • Concha, Angel
  • Machado, Isidro|||0000-0001-7318-1330
  • Maurel, Joan|||0000-0002-9413-5592
  • Chic, Nuria
  • Castells, Antoni|||0000-0001-8431-2033
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Camps Polo, Jordi|||0000-0003-2929-4228
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
Recurrence of stage II (pT3-T4 pN0) colorectal cancer (CRC) occurs in about 15% of patients and it is often due to undetected lymph node (LN) metastases with conventional pathology haematoxylin and eosin (H&E) LN analysis. Despite more sensitive molecular methods of LN staging having proved to have prognostic value in stage II CRC, we aimed at determining whether the pN stage could be better assessed with LN cytology smears. We analysed 3936 LNs from 217 CRC surgical resections, using three methods, H&E, cytology smears, and the One Step Nucleic Acid Amplification (OSNA) molecular assay. We compared the pN stages obtained from both H&E and cytology, as well as with the OSNA results. We concluded that LN analysis with cytology smears not only enables performing the pN stage, but detects more LN metastases than H&E, with a similar detection rate to molecular methods. Cytology LN analysis would allow a better patient therapeutic management. Stage II colorectal cancer (CRC) recurrence remains a clinical problem. Some of these patients are true stage III CRC with a pN0 pathology stage. This large prospective multicentre cohort study aimed at evaluating the diagnostic ability of lymph node (LN) cytology smears to perform the pN stage and compare it with the conventional haematoxylin and eosin (H&E) pathology pN stage. Additionally, we used the One-Step Nucleic Acid Amplification (OSNA), a high-sensitive molecular method of LN staging. A total of 3936 fresh LNs from 217 CRC surgical specimens were examined by three methods, H&E, LN cytology smears, and OSNA. H&E detected 29% of patients with positive LNs, cytology smears 35%, and OSNA 33.2% (p < 0.0001). H&E and cytology concordantly classified 92.2% of tumours, and 88.5% between OSNA and H&E. Cytology had 96.8% sensitivity and 90.3% specificity to discriminate positive/negative patients compared to H&E (p = 0.004), and 87.3% sensitivity and 89% specificity when compared to OSNA (p = 0.56). Patients with positive LNs detected by any of the three methods had significantly worse disease-free and overall survival. We conclude that pN stage accuracy for detecting positive LNs is superior with LN cytological smears than with conventional H&E, which would enable a better pN stage and management of early-stage CRC patients.